Replies to post #70663 on Biotech Values

[DewDiligence]

KG doesn’t mind divesting Kadian because they would’ve ceased promoting it anyhow upon launching Embeda. In other words, anything KG can get for Kadian is essentially free money.

[DewDiligence]

Actavis picks up Kadian from KG:

http://finance.yahoo.com/news/Actavis-Acquires-Kadian-bw-13934317.html

I suppose there’s a little life left in the brand even with Embeda on the way.